BBVA
RNAC icon

Banco Bilbao Vizcaya Argentaria’s Cartesian Therapeutics RNAC Stock Holding History

Banco Bilbao Vizcaya Argentaria’s Portfolio RNAC Stock Details RNAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-18,040
Closed -$1.54M – 740
2020
Q2 		$1.54M Buy
+18,040
New +$1.64M 0.05% 289

Other funds holding RNAC

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MP
Mangrove Partners Greenwich, Connecticut $1.24B AUM 41.74% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
MWNA
Marshall Wace North America New York $23.5B AUM 46.46% 1-Year Est. Return
PVMCV
Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return

Banco Bilbao Vizcaya Argentaria's RNAC Position: Q3 2020 in Review

Banco Bilbao Vizcaya Argentaria sold out of Cartesian Therapeutics (RNAC) in Q3 2020, closing a stake of 18,040 shares — an estimated $1.54M sold.

Banco Bilbao Vizcaya Argentaria first reported a position in RNAC in Q2 2020 and held it in 1 quarter. The position peaked at $1.54M in Q2 2020. 79 funds tracked by Wall St. Rank hold RNAC as of Q3 2020.

  • Banco Bilbao Vizcaya Argentaria reported no remaining Cartesian Therapeutics position as of Q3 2020 after selling out during the quarter.
  • Banco Bilbao Vizcaya Argentaria sold 18,040 Cartesian Therapeutics shares in Q3 2020, an estimated $1.54M.
  • Banco Bilbao Vizcaya Argentaria first reported a position in Cartesian Therapeutics in Q2 2020 and held it in 1 quarter.
  • Banco Bilbao Vizcaya Argentaria's Cartesian Therapeutics position peaked at $1.54M in Q2 2020.
  • 79 funds tracked by Wall St. Rank held Cartesian Therapeutics as of Q3 2020.

Based on Banco Bilbao Vizcaya Argentaria's 13F filing for Q3 2020, filed 12 Nov 2020.